OCUL compared with MLTX: revenue, margins and what each company keeps, and the suppliers and customers both name

OCULOcular Therapeutix, Inc

Mkt capRevenueRevenue

MLTXMoonLake Immunotherapeutics

Mkt capRevenueRevenue

Compare

OCULOcular Therapeutix, Inc

MLTXMoonLake Immunotherapeutics

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OCUL 7

—Inceptunlistedsupplier

—Ambulatory surgery centersunlistedcustomer

—Hospital outpatient departmentsunlistedcustomer

—Physicians' officesunlistedcustomer

3 more · OCUL chain ›

Shared 0

No shared counterparties.

Only MLTX 1

—Merck Healthcare KGaA, Darmstadt, Germanyunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

OCULOcular Therapeutix, Inc

6.98▼−4.54%· post 6.98

Mkt cap$1.5BRevenue$13MQ2 FY26Revenue$52MFY25

MLTXMoonLake Immunotherapeutics

11.78▼−6.28%· post 11.78

ClosedOct 30 '26

Mkt cap$1.0BRevenue—Revenue—

Compare

ClosedOct 30 '26

OCULOcular Therapeutix, Inc

MLTXMoonLake Immunotherapeutics

6.98▼−4.54%post 6.98

Price

11.78▼−6.28%post 11.78

$1.5B

Mkt cap

$1.0B

Q2 FY26$13M

Revenue

—

FY25$52M

Revenue

—

OCUL6.98▼−4.54%vsMLTX11.78▼−6.28%ClosedOct 30 '26